Skin conditions (dermatitis, eczema, psoriasis) decisions — 2025

The Board denied service connection for a respiratory disorder and an initial disability rating in excess of 10 percent for pseudofolliculitis barbae.

The Board denied the veteran's claims for increased ratings and dismissed the claims for compensable ratings, except for remanding two service connection claims.

The Board remands the claims for dermatitis and hypertension as further development is needed.

The Board granted service connection for tinea pedis, right and left foot, finding the conditions were causally related to the Veteran's active-duty service.

The Board denied service connection for GERD, shortness of breath, an initial compensable disability rating for allergic rhinitis, and an initial compensable disability rating for smallpox scar. The acne claim was remanded.

The claims for increased ratings for the Veteran's service-connected conditions are being remanded to provide him an additional opportunity to undergo VA examinations.

The Board remands the matter for an additional VA examination to properly evaluate the severity of the Veteran's service-connected contact dermatitis, as the previous opinion was found inadequate.

The Board dismissed the appeals for service connection for various conditions as a matter of law due to claims processing errors preventing concurrent review.

The Board remands the claims for service connection for type II diabetes mellitus, eczema (claimed as a skin disability), and erectile dysfunction to schedule new VA examinations.

The Board denied service connection for pseudofolliculitis barbae (PFB) and associated facial scarring as there is no current diagnosis of the condition.

The Board denied a compensable disability rating for pseudofolliculitis barbae and tinea versicolor with psoriasis affecting the left great toe prior to June 4, 2022 and from June 4, 2023. However, it granted a 10 percent disability rating for TV affecting the left great toe from June 4, 2022 to June 4, 2023.

The Board denied the veteran's claims for an increased rating for tension type headaches, a compensable rating for pseudofolliculitis barbae, and service connection for left and right elbow conditions.

The Board granted a rating of 60 percent for the skin disability, to include pseudofolliculitis barbae and tinea versicolor, effective June 21, 2022.

The Board remands the claims for an increased rating for the Veteran's left shoulder disability and tinea cruris to correct duty to assist errors.

The Board denied an initial compensable rating for chloracne, finding it did not meet the criteria for a 10 percent evaluation under DC 7829.

The Board remands the claim for a rating in excess of 10 percent for acne keloidalis nuchae to schedule an examination to assess scarring and determine if a higher rating is warranted.

The appeal of a proposed reduction in the disability rating for service-connected psoriasis from 30 percent to 0 percent was dismissed as it was not a final decision.

The Board remands the claim for service connection for pseudofolliculitis barbae to obtain a supplemental medical opinion addressing the Veteran's contentions and noted risk factors.

The Board denied the veteran's claims for increased ratings and service connection, as well as remanded several issues for further development.

The Board denied an increased rating for tinnitus and granted higher ratings for the low back disability, right and left lower extremity sciatic radiculopathy.